Potentiating antimicrobial efficacy of propolis through niosomal-based system for administration

Alencar, 2007, Chemical composition and biological activity of a new type of Brazilian propolis: red propolis, J Ethnopharmacol, 113, 278, 10.1016/j.jep.2007.06.005 Fokt, 2010, How do bees prevent hive infections? The antimicrobial properties of propolis, Vol. 1, 481 Ghisalberti, 1979, Propolis: a review [honey-bees], Bee World, 60, 59, 10.1080/0005772X.1979.11097738 De Castro, 2001, Propolis: biological and pharmacological activities. Therapeutic uses of this bee-product, Ann Rev Biol Sci, 3, 49 Bankova, 2009, Chemical diversity of propolis makes it a valuable source of new biologically active compounds, J ApiProd ApiMed Sci, 1, 23, 10.3896/IBRA.4.01.2.01 Burdock, 1998, Review of the biological properties and toxicity of bee propolis (propolis), Food Chem Toxicol, 36, 347, 10.1016/S0278-6915(97)00145-2 Hegazi, 2002, Egyptian propolis: 3. Antioxidant, antimicrobial activities and chemical composition of propolis from reclaimed lands, Z Naturforsch C, 57, 395, 10.1515/znc-2002-3-432 Kujumgiev, 1999, Antibacterial, antifungal and antiviral activity of propolis of different geographic origin, J Ethnopharmacol, 64, 235, 10.1016/S0378-8741(98)00131-7 Kumazawa, 2004, Antioxidant activity of propolis of various geographic origins, Food Chem, 84, 329, 10.1016/S0308-8146(03)00216-4 Marcucci, 1995, Propolis: chemical composition, biological properties and therapeutic activity, Apidologie (Celle), 26, 83, 10.1051/apido:19950202 Park, 1998, Antimicrobial activity of propolis on oral microorganisms, Curr Microbiol, 36, 24, 10.1007/s002849900274 Pontin, 2008, In vitro and in vivo antileishmanial activities of a Brazilian green propolis extract, Parasitol Res, 103, 487, 10.1007/s00436-008-0970-z Kalogeropoulos, 2009, Chemical composition, antioxidant activity and antimicrobial properties of propolis extracts from Greece and Cyprus, Food Chem, 116, 452, 10.1016/j.foodchem.2009.02.060 Mirzoeva, 1997, Antimicrobial action of propolis and some of its components: the effects on growth, membrane potential and motility of bacteria, Microbiol Res, 152, 239, 10.1016/S0944-5013(97)80034-1 Oliveira, 2006, Antifungal activity of propolis extract against yeasts isolated from onychomycosis lesions, Mem Inst Oswaldo Cruz, 101, 493, 10.1590/S0074-02762006000500002 Motior Rahman, 2010, Antibacterial activity of propolis and honey against Staphylococcus aureus and Escherichia coli, Afr J Microbiol Res, 4, 1872 Ghasem, 2007, Antibacterial and antifungal activity of Iranian propolis against Staphylococcus aureus and Candida albicans, Pak J Biol Sci, 10, 1343, 10.3923/pjbs.2007.1343.1345 Takaisi-Kikuni, 1994, Electron microscopic and microcalorimetric investigations of the possible mechanism of the antibacterial action of a defined propolis provenance, Planta Med, 60, 222, 10.1055/s-2006-959463 Manconi, 2002, Niosomes as carriers for tretinoin. I. Preparation and properties, Int J Pharm, 234, 237, 10.1016/S0378-5173(01)00971-1 Sahin, 2007, Niosomes as nanocarrier systems, 67 Balakrishnan, 2009, Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery, Int J Pharm, 377, 1, 10.1016/j.ijpharm.2009.04.020 Hofland, 1991, Interactions of non-ionic surfactant vesicles with cultured keratinocytes and human skin in vitro: a survey of toxicological aspects and ultrastructural changes in stratum corneum, J Control Release, 16, 155, 10.1016/0168-3659(91)90039-G Hofland, 1995, Interactions between non-ionic surfactant vesicles and human stratum corneum in vitro, J Liposome Res, 5, 241, 10.3109/08982109509018629 Uchegbu, 1995, Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry, Adv Colloid Interface Sci, 58, 1, 10.1016/0001-8686(95)00242-I Uchegbu, 1998, Non-ionic surfactant based vesicles (niosomes) in drug delivery, Int J Pharm, 172, 33, 10.1016/S0378-5173(98)00169-0 Ambardekar, 2012, Enhancement of hepatoprotective efficacy of propolis by fabrication of liposomes, as a platform nano-formulation for multi-component natural medicine, Curr Drug Deliv, 9, 477, 10.2174/156720112802650653 Trusheva, 2007, Different extraction methods of biologically active components from propolis: a preliminary study, Chem Cent J, 1, 13, 10.1186/1752-153X-1-13 González, 2003, Spectrophotometric determination of phenolic compounds in propolis, Acta Farm Bonaer, 22, 243 Ceschel, 2002, In vitro permeation through porcine buccal mucosa of caffeic acid phenetyl ester (CAPE) from a topical mucoadhesive gel containing propolis, Fitoterapia, 73, S44, 10.1016/S0367-326X(02)00190-9 Marquele-Oliveira, 2007, Development of topical functionalized formulations added with propolis extract: stability, cutaneous absorption and in vivo studies, Int J Pharm, 342, 40, 10.1016/j.ijpharm.2007.04.026 Nasseri, 2005, Effect of cholesterol and temperature on the elastic properties of niosomal membranes, Int J Pharm, 300, 95, 10.1016/j.ijpharm.2005.05.009 Shaikh, 2010, Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine, Drug Dev Ind Pharm, 36, 946, 10.3109/03639040903585150 Manosroi, 2003, Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol, Colloids Surf B Biointerfaces, 30, 129, 10.1016/S0927-7765(03)00080-8 Bernsdorff, 1997, Effect of hydrostatic pressure on water penetration and rotational dynamics in phospholipid-cholesterol bilayers, Biophys J, 72, 1264, 10.1016/S0006-3495(97)78773-3 Kirby, 1980, Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro, Biochem J, 186, 591, 10.1042/bj1860591 Mugabe, 2005, Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients, J Antimicrob Chemother, 55, 269, 10.1093/jac/dkh518 Moazeni, 2010, Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery, J Microencapsul, 27, 618, 10.3109/02652048.2010.506579 Bonacucina, 2008, Rheological evaluation of silicon/Carbopol hydrophilic gel systems as a vehicle for delivery of water insoluble drugs, AAPS J, 10, 84, 10.1208/s12248-008-9008-9